itraconazole has been researched along with Aspergillosis in 11 studies
Aspergillosis: Infections with fungi of the genus ASPERGILLUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral posaconazole therapy was started 24 h after infection and was given once daily for 14 consecutive days." | 1.36 | Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene. ( Brüggemann, RJ; Mavridou, E; Melchers, WJ; Mouton, JW; Verweij, PE, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartroli, J | 2 |
| Turmo, E | 2 |
| Algueró, M | 2 |
| Boncompte, E | 2 |
| Vericat, ML | 2 |
| Conte, L | 2 |
| Ramis, J | 2 |
| Merlos, M | 2 |
| García-Rafanell, J | 2 |
| Forn, J | 2 |
| Ohwada, J | 1 |
| Tsukazaki, M | 1 |
| Hayase, T | 1 |
| Oikawa, N | 1 |
| Isshiki, Y | 1 |
| Fukuda, H | 1 |
| Mizuguchi, E | 1 |
| Sakaitani, M | 1 |
| Shiratori, Y | 1 |
| Yamazaki, T | 1 |
| Ichihara, S | 1 |
| Umeda, I | 1 |
| Shimma, N | 1 |
| Fritsche, TR | 1 |
| Rhomberg, PR | 1 |
| Sader, HS | 1 |
| Jones, RN | 1 |
| Troke, P | 1 |
| Aguirrebengoa, K | 1 |
| Arteaga, C | 1 |
| Ellis, D | 1 |
| Heath, CH | 1 |
| Lutsar, I | 1 |
| Rovira, M | 1 |
| Nguyen, Q | 1 |
| Slavin, M | 1 |
| Chen, SC | 1 |
| Rodriguez-Tudela, JL | 2 |
| Alcazar-Fuoli, L | 1 |
| Mellado, E | 1 |
| Alastruey-Izquierdo, A | 2 |
| Monzon, A | 1 |
| Cuenca-Estrella, M | 2 |
| Seidler, MJ | 1 |
| Salvenmoser, S | 1 |
| Müller, FM | 1 |
| Lass-Flörl, C | 2 |
| Perkhofer, S | 1 |
| Arendrup, MC | 1 |
| Garcia-Effron, G | 1 |
| Buzina, W | 1 |
| Mortensen, KL | 1 |
| Reiter, N | 1 |
| Lundin, C | 1 |
| Jensen, HE | 1 |
| Perlin, DS | 1 |
| Bruun, B | 1 |
| Beernaert, LA | 1 |
| Pasmans, F | 1 |
| Van Waeyenberghe, L | 1 |
| Dorrestein, GM | 1 |
| Verstappen, F | 1 |
| Vercammen, F | 1 |
| Haesebrouck, F | 1 |
| Martel, A | 1 |
| Mavridou, E | 1 |
| Brüggemann, RJ | 1 |
| Melchers, WJ | 1 |
| Mouton, JW | 1 |
| Verweij, PE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome. A Prospective Multicenter Observational Study.[NCT03121235] | 320 participants (Actual) | Observational | 2017-04-20 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 other studies available for itraconazole and Aspergillosis
| Article | Year |
|---|---|
New azole antifungals. 2. Synthesis and antifungal activity of heterocyclecarboxamide derivatives of 3-amino-2-aryl-1-azolyl-2-butanol.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbi | 1998 |
New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbi | 1998 |
Design, synthesis and antifungal activity of a novel water soluble prodrug of antifungal triazole.
Topics: Animals; Antifungal Agents; Aspergillosis; Biotransformation; Candidiasis; Chemical Phenomena; Chemi | 2003 |
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillosis; Aspergillus; Candida; Candidiasis | 2008 |
Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Child; Child, Preschoo | 2008 |
Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome | 2008 |
Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biofilms; Bronchi; Cells, Cultured; Cystic | 2008 |
In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; DNA, Fungal; Humans; Microbial Sensitivity Tests; Soi | 2009 |
Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Cas | 2009 |
Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole.
Topics: Amphotericin B; Animals; Animals, Domestic; Animals, Wild; Antifungal Agents; Aspergillosis; Aspergi | 2009 |
Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene.
Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumig | 2010 |